Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial

The emergence of highly pathogenic avian influenza H5N1 viruses has raised concerns about their pandemic potential. Vaccination is the most effective way of preventing influenza. In this study, we investigated the safety and immunogenicity of an avian H5N2 live attenuated influenza vaccine (LAIV H5N...

Full description

Saved in:
Bibliographic Details
Published inThe Lancet infectious diseases Vol. 17; no. 8; pp. 833 - 842
Main Authors Pitisuttithum, Punnee, Boonnak, Kobporn, Chamnanchanunt, Supat, Puthavathana, Pilaipan, Luvira, Viravarn, Lerdsamran, Hatairat, Kaewkungwal, Jaranit, Lawpoolsri, Saranath, Thanachartwet, Vipa, Silachamroon, Udomsak, Masamae, Wanibtisam, Schuetz, Alexandra, Wirachwong, Ponthip, Thirapakpoomanunt, Sit, Rudenko, Larisa, Sparrow, Erin, Friede, Martin, Kieny, Marie-Paule
Format Journal Article
LanguageEnglish
Published United States Elsevier Ltd 01.08.2017
Elsevier Limited
Elsevier Science ;, The Lancet Pub. Group
Subjects
Online AccessGet full text

Cover

Loading…